Patent details

EP1259512 Title: PTERIDINE COMPOUNDS FOR THE TREATMENT OF PSORIASIS

Basic Information

Publication number:
EP1259512
PCT Application Number:
PCT/SE/01/00374
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP019064930
PCT Publication Number:
WO/01/06275
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PTERIDINE COMPOUNDS FOR THE TREATMENT OF PSORIASIS
French Title of Invention:
COMPOSES DE PTERIDINE DESTINES AU TRAITEMENT DU PSORIASIS
German Title of Invention:
PIPERIDIN VERBINDUNG ZUR BEHANDLUNG VON PSORIASIS
SPC Number:

Dates

Filing date:
20/02/2001
Grant date:
24/09/2003
EP Publication Date:
24/09/2003
PCT Publication Date:
30/08/2001
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
27/11/2002
EP B1 Publication Date:
24/09/2003
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
20/02/2012
Expiration date:
20/02/2021
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
20/02/2001
 
 

Name:
AstraZeneca AB
Address:
-, 151 85 Södertälje, Sweden (SE)

Agent

Name:
ARONOVA S.A.
From:
28/11/2003
Address:
PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Inventor

1

Name:
Hunt Fraser
Address:
United Kingdom (GB)

2

Name:
Bonnert Roger
Address:
United Kingdom (GB)

3

Name:
Gardiner Stewart
Address:
United Kingdom (GB)

4

Name:
Walters Iain
Address:
United Kingdom (GB)

Priority

Priority Number:
0004128
Priority Date:
23/02/2000
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
C07D 475/00;
Filing date Document type Number of pages